Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 2Completed 1

Sponsor Class

OTHER 11OTHER_GOV 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Cancer Liver Metastases 1Hemorrhage 1Anastomotic Leak 1

Interventions

tislelizumab 12Capecitabine 8Carboplatin 5Surgical Procedures, Operative 4Oxaliplatin 4Drug Therapy 4apatinib 3Paclitaxel 3Cisplatin 3Bevacizumab 3ivarmacitinib 2anlotinib 2Standard of Care 2Radiotherapy 2Radiation 2Methods 2Melphalan 2Low-Level Light Therapy 2Letrozole 2Interleukin-2 2Injections 2Immunotherapy 2Cryotherapy 2zanubrutinib 1trastuzumab deruxtecan 1toripalimab 1surufatinib 1sintilimab 1pyrotinib 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER_GOV × Methods × Clear all
NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Shandong Provincial Hospital

Phase 2 Not yet recruiting
38 enrolled
Gastrointestinal

Pancreatic Cancer Liver Metastases

NCT06049758 2023-09-22

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

General Committee of Teaching Hospitals and Institutes, Egypt

Phase NA Not yet recruiting
80 enrolled

Hemorrhage, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡